Physician profile
Nancy Tran
NPI 1174383418
$792.79
in general payments reported to CMS, 2019-2025
17 companies · $674 in 2025
The $674 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $119 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $100.27 | 2024 | Keytruda |
| Astrazeneca Pharmaceuticals Lp | $100.00 | 2025 | |
| Dendreon Pharmaceuticals LLC | $89.34 | 2025 | Provenge |
| Gilead Sciences, INC. | $89.19 | 2025 | Trodelvy |
| Endo USA, INC. | $74.07 | 2025 | Xiaflex |
| Antares Pharma, INC. | $53.82 | 2025 | Xyosted |
| Astellas Pharma US INC | $52.31 | 2025 | Xtandi |
| Abbvie INC. | $42.80 | 2025 | |
| Telix Pharmaceuticals | $30.48 | 2025 | Illuccix |
| Urogen Pharma, INC. | $26.75 | 2025 | |
| Teleflex LLC | $25.96 | 2025 | Barrigel |
| 180 Medical, INC. | $22.90 | 2025 | |
| Corium, LLC | $18.34 | 2024 | Azstarys |
| Baxter Healthcare | $17.74 | 2025 | Perclot |
| Boston Scientific Corporation | $17.13 | 2025 | Axonics |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bluewind Medical | $16.18 | 2025 | Revi |
| Bayer Healthcare Pharmaceuticals INC. | $15.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.